Transaction in Own Shares

RNS Number : 5716E

Hikma Pharmaceuticals Plc

11 March 2022

 

Hikma Pharmaceuticals PLC

Share Buyback Programme

London, 11 March 2022

Hikma Pharmaceuticals PLC ("Hikma") announces today that it has purchased the following number of its ordinary shares on the London Stock Exchange and/or on BATS and/or on Chi-X trading venues from Citigroup Global Markets Limited ("Citi"). The repurchased shares will be cancelled.

	London Stock Exchange	BATS Trading Venue	Chi-X Trading Venue
Number of ordinary shares purchased:	10,599	6,418	-
Highest price paid (per ordinary share):	£19.8300	£19.8300	-
Lowest price paid (per ordinary share):	£19.7950	£19.7950	-
Volume weighted average price paid (per ordinary share):	£19.8183	£19.8169	-

Such purchases form part of Hikma's share buyback programme announced on 24 February 2022.

Following the settlement of the above purchases and cancellation of the purchased ordinary shares, the total number of ordinary shares in issue shall be 243,701,581 ordinary shares and the total number of ordinary shares held in treasury is 12,833,233 ordinary shares. Therefore, following the above purchases total voting rights are 230,868,348 ordinary shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the detailed breakdown of individual trades made by Citi on behalf of Hikma as part of the buyback programme is set out below.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

Schedule of Purchases - Individual Transactions

Date of Transaction	Time of Transaction	Number of Shares	Price Per Share (GBp)	Trading Venue	Transaction Reference Number
11/03/2022	16:13:17	140	1,980.00	BATE	xsqArH2G6TD
11/03/2022	16:12:37	175	1,979.50	XLON	xsqArH2G7nC
11/03/2022	16:12:31	43	1,980.00	XLON	xsqArH2G7@e
11/03/2022	16:12:31	103	1,980.00	XLON	xsqArH2G7@g
11/03/2022	16:12:31	138	1,980.00	BATE	xsqArH2G7@i
11/03/2022	16:12:02	135	1,980.00	XLON	xsqArH2G7BH
11/03/2022	16:11:52	46	1,980.50	XLON	xsqArH2G7I7
11/03/2022	16:11:52	38	1,980.50	XLON	xsqArH2G7I9
11/03/2022	16:11:52	97	1,980.50	BATE	xsqArH2G7IB
11/03/2022	16:11:43	123	1,981.00	BATE	xsqArH2G7Rh
11/03/2022	16:11:43	112	1,981.00	XLON	xsqArH2G7Rf
11/03/2022	16:11:37	131	1,981.50	BATE	xsqArH2G4dW
11/03/2022	16:11:37	84	1,981.50	XLON	xsqArH2G4aS
11/03/2022	16:11:37	35	1,981.50	XLON	xsqArH2G4aU
11/03/2022	16:11:28	19	1,982.00	XLON	xsqArH2G4jH
11/03/2022	16:11:28	117	1,982.00	BATE	xsqArH2G4jL
11/03/2022	16:11:28	127	1,982.00	XLON	xsqArH2G4jJ
11/03/2022	16:10:35	28	1,982.00	BATE	xsqArH2G4BU
11/03/2022	16:10:35	18	1,982.00	BATE	xsqArH2G4AW
11/03/2022	16:10:35	75	1,982.00	BATE	xsqArH2G4AY
11/03/2022	16:10:22	54	1,983.00	XLON	xsqArH2G4IL
11/03/2022	16:07:35	117	1,982.50	BATE	xsqArH2G2K8
11/03/2022	16:07:32	72	1,983.00	XLON	xsqArH2G2NT
11/03/2022	16:07:32	139	1,983.00	BATE	xsqArH2G2MX
11/03/2022	16:07:30	6	1,983.00	BATE	xsqArH2G2GW
11/03/2022	16:07:30	389	1,983.00	BATE	xsqArH2G2GY
11/03/2022	16:07:30	175	1,983.00	XLON	xsqArH2G2Ga
11/03/2022	16:07:21	548	1,983.00	XLON	xsqArH2G2Rh
11/03/2022	14:10:20	127	1,982.00	BATE	xsqArH2I@B@
11/03/2022	14:08:41	51	1,982.00	BATE	xsqArH2I$Me
11/03/2022	14:08:41	13	1,982.00	BATE	xsqArH2I$Mi
11/03/2022	14:08:41	94	1,982.00	XLON	xsqArH2I$Mg
11/03/2022	14:08:41	202	1,982.50	XLON	xsqArH2I$Mk
11/03/2022	14:08:41	68	1,982.50	BATE	xsqArH2I$Mm
11/03/2022	14:08:41	30	1,982.50	BATE	xsqArH2I$Mo
11/03/2022	14:08:41	206	1,983.00	BATE	xsqArH2I$Mw
11/03/2022	14:08:41	15	1,983.00	BATE	xsqArH2I$M@
11/03/2022	14:08:41	493	1,983.00	XLON	xsqArH2I$Mu
11/03/2022	13:55:34	75	1,983.00	XLON	xsqArH2IcQm
11/03/2022	13:54:48	135	1,983.00	XLON	xsqArH2Idum
11/03/2022	13:52:46	54	1,983.00	BATE	xsqArH2Iam6
11/03/2022	13:49:29	2	1,983.00	BATE	xsqArH2IYXe
11/03/2022	13:49:29	21	1,983.00	BATE	xsqArH2IYXg
11/03/2022	13:49:29	63	1,983.00	BATE	xsqArH2IYXi
11/03/2022	13:01:40	102	1,983.00	XLON	xsqArH2IRT6
11/03/2022	13:01:40	6	1,983.00	BATE	xsqArH2IRT8
11/03/2022	13:01:40	116	1,983.00	BATE	xsqArH2IRTA
11/03/2022	11:37:39	96	1,983.00	XLON	xsqArH2JZ29
11/03/2022	11:23:16	108	1,980.50	XLON	xsqArH2JMyx
11/03/2022	11:23:16	53	1,981.00	XLON	xsqArH2JMy8
11/03/2022	11:23:16	73	1,981.00	XLON	xsqArH2JMyA
11/03/2022	11:23:11	190	1,981.50	XLON	xsqArH2JM@S
11/03/2022	11:23:11	36	1,982.00	XLON	xsqArH2JMvW
11/03/2022	11:23:11	400	1,982.00	XLON	xsqArH2JMvY
11/03/2022	11:20:15	120	1,982.50	BATE	xsqArH2JN43
11/03/2022	11:20:15	117	1,982.50	XLON	xsqArH2JN4z
11/03/2022	11:20:15	139	1,982.50	XLON	xsqArH2JN4$
11/03/2022	11:19:09	167	1,982.50	XLON	xsqArH2JNTW
11/03/2022	11:18:54	279	1,983.00	XLON	xsqArH2JNO4
11/03/2022	11:18:54	173	1,983.00	BATE	xsqArH2JNO6
11/03/2022	11:14:32	102	1,983.00	BATE	xsqArH2JL6U
11/03/2022	11:12:19	10	1,982.50	XLON	xsqArH2JIzZ
11/03/2022	11:12:19	54	1,982.50	XLON	xsqArH2JIzf
11/03/2022	11:12:19	12	1,982.50	XLON	xsqArH2JIzh
11/03/2022	11:12:19	40	1,982.50	XLON	xsqArH2JIzo
11/03/2022	11:12:19	154	1,982.50	XLON	xsqArH2JIzq
11/03/2022	11:12:19	138	1,982.00	XLON	xsqArH2JIz3
11/03/2022	11:12:09	59	1,980.00	XLON	xsqArH2JIuX
11/03/2022	11:11:41	154	1,980.00	BATE	xsqArH2JIM9
11/03/2022	11:11:01	3	1,980.50	BATE	xsqArH2JJfs
11/03/2022	11:10:58	306	1,981.50	BATE	xsqArH2JJhY
11/03/2022	11:10:58	16	1,981.50	BATE	xsqArH2JJha
11/03/2022	11:10:56	95	1,981.50	BATE	xsqArH2JJgH
11/03/2022	11:10:56	68	1,981.50	BATE	xsqArH2JJgJ
11/03/2022	11:10:56	100	1,980.50	BATE	xsqArH2JJgT
11/03/2022	11:10:56	40	1,981.50	BATE	xsqArH2JJr@
11/03/2022	11:10:56	119	1,980.50	XLON	xsqArH2JJr9
11/03/2022	11:10:56	80	1,981.00	XLON	xsqArH2JJrJ
11/03/2022	11:10:56	194	1,981.00	XLON	xsqArH2JJrL
11/03/2022	11:10:56	6	1,981.00	BATE	xsqArH2JJrN
11/03/2022	11:10:56	96	1,981.00	BATE	xsqArH2JJrP
11/03/2022	11:09:43	19	1,981.50	BATE	xsqArH2JJN0
11/03/2022	11:09:24	21	1,980.00	BATE	xsqArH2JJQr
11/03/2022	11:09:24	157	1,980.00	XLON	xsqArH2JJQs
11/03/2022	11:09:24	119	1,979.50	XLON	xsqArH2JJQ9
11/03/2022	11:09:24	24	1,979.50	BATE	xsqArH2JJQB
11/03/2022	11:09:24	38	1,979.50	BATE	xsqArH2JJQD
11/03/2022	11:09:24	108	1,980.00	BATE	xsqArH2JJQH
11/03/2022	11:09:24	85	1,980.00	XLON	xsqArH2JJQF
11/03/2022	11:09:24	189	1,980.00	XLON	xsqArH2JJQJ
11/03/2022	11:08:04	131	1,980.50	XLON	xsqArH2JG2K
11/03/2022	11:05:45	55	1,980.50	XLON	xsqArH2JH7Y
11/03/2022	11:05:45	158	1,980.50	XLON	xsqArH2JH7y
11/03/2022	11:05:36	38	1,980.50	XLON	xsqArH2JH0f
11/03/2022	11:05:36	51	1,980.00	XLON	xsqArH2JH0t
11/03/2022	11:04:38	5	1,980.00	BATE	xsqArH2JHSH
11/03/2022	11:04:38	200	1,980.00	BATE	xsqArH2JHSJ
11/03/2022	11:04:38	25	1,980.00	BATE	xsqArH2JHSL
11/03/2022	11:04:38	33	1,980.00	BATE	xsqArH2JHSP
11/03/2022	11:03:42	68	1,979.50	XLON	xsqArH2JUey
11/03/2022	11:03:42	119	1,980.00	XLON	xsqArH2JUe0
11/03/2022	11:03:39	53	1,980.50	XLON	xsqArH2JUhB
11/03/2022	11:03:39	200	1,980.50	XLON	xsqArH2JUhD
11/03/2022	11:03:39	21	1,980.50	XLON	xsqArH2JUhF
11/03/2022	11:03:39	88	1,981.00	BATE	xsqArH2JUhJ
11/03/2022	11:03:39	149	1,981.50	BATE	xsqArH2JUhH
11/03/2022	11:03:38	224	1,983.00	XLON	xsqArH2JUgo
11/03/2022	11:03:38	63	1,983.00	XLON	xsqArH2JUgq
11/03/2022	11:03:38	32	1,983.00	XLON	xsqArH2JUgs
11/03/2022	11:03:38	192	1,983.00	XLON	xsqArH2JUg$
11/03/2022	11:03:37	195	1,983.00	XLON	xsqArH2JUg5
11/03/2022	11:03:37	1	1,983.00	XLON	xsqArH2JUgB
11/03/2022	11:03:37	130	1,983.00	XLON	xsqArH2JUgD
11/03/2022	11:03:37	32	1,983.00	XLON	xsqArH2JUgF
11/03/2022	11:03:37	145	1,983.00	XLON	xsqArH2JUrh
11/03/2022	11:03:37	32	1,983.00	XLON	xsqArH2JUrj
11/03/2022	11:03:37	62	1,983.00	XLON	xsqArH2JUrs
11/03/2022	11:03:37	13	1,983.00	XLON	xsqArH2JUr3
11/03/2022	11:03:37	102	1,983.00	XLON	xsqArH2JUr5
11/03/2022	11:03:37	84	1,980.50	BATE	xsqArH2JUrU
11/03/2022	11:03:37	112	1,980.50	BATE	xsqArH2JUqa
11/03/2022	11:03:37	274	1,980.50	XLON	xsqArH2JUqi
11/03/2022	11:02:35	50	1,981.50	BATE	xsqArH2JUMv
11/03/2022	11:02:35	61	1,981.50	BATE	xsqArH2JUMJ
11/03/2022	11:02:35	50	1,981.50	BATE	xsqArH2JUH3
11/03/2022	11:02:35	259	1,981.50	BATE	xsqArH2JUHL
11/03/2022	11:02:22	4	1,981.50	BATE	xsqArH2JUON
11/03/2022	11:02:22	7	1,981.50	BATE	xsqArH2JUOP
11/03/2022	11:02:01	45	1,981.50	BATE	xsqArH2JVWt
11/03/2022	11:02:01	273	1,981.00	XLON	xsqArH2JVW2
11/03/2022	11:02:01	99	1,981.00	BATE	xsqArH2JVW8
11/03/2022	10:59:54	102	1,981.50	BATE	xsqArH2JSdf
11/03/2022	10:58:51	103	1,981.00	BATE	xsqArH2JS7J
11/03/2022	10:58:51	60	1,981.00	BATE	xsqArH2JS7L
11/03/2022	10:58:51	118	1,980.00	XLON	xsqArH2JS6g
11/03/2022	10:58:51	50	1,980.00	BATE	xsqArH2JS6e
11/03/2022	10:58:51	18	1,980.00	BATE	xsqArH2JS6i
11/03/2022	10:58:51	152	1,980.50	XLON	xsqArH2JS6m
11/03/2022	10:58:51	46	1,980.50	XLON	xsqArH2JS6o
11/03/2022	10:58:51	75	1,980.50	XLON	xsqArH2JS6q
11/03/2022	10:58:51	4	1,980.50	BATE	xsqArH2JS6y
11/03/2022	10:58:51	98	1,980.50	BATE	xsqArH2JS6@
11/03/2022	10:55:08	67	1,981.50	XLON	xsqArH2JQ@M
11/03/2022	10:55:08	102	1,982.00	XLON	xsqArH2JQ@R
11/03/2022	10:54:46	42	1,982.00	XLON	xsqArH2JQCu
11/03/2022	10:54:46	183	1,982.50	XLON	xsqArH2JQFw
11/03/2022	10:54:46	125	1,983.00	BATE	xsqArH2JQF@
11/03/2022	10:54:46	422	1,983.00	XLON	xsqArH2JQFy
11/03/2022	10:27:24	64	1,983.00	BATE	xsqArH2JEPx
11/03/2022	10:27:24	51	1,983.00	BATE	xsqArH2JEPz
11/03/2022	10:27:12	100	1,983.00	BATE	xsqArH2JFdI
11/03/2022	10:27:12	99	1,983.00	BATE	xsqArH2JFcX
11/03/2022	10:18:20	59	1,980.50	XLON	xsqArH2JBtm
11/03/2022	10:18:20	71	1,980.50	BATE	xsqArH2JBto
11/03/2022	10:18:18	2	1,981.00	XLON	xsqArH2JBtR
11/03/2022	10:18:18	76	1,981.00	XLON	xsqArH2JBtT
11/03/2022	10:18:18	78	1,981.00	BATE	xsqArH2JBtV
11/03/2022	10:18:14	104	1,982.50	BATE	xsqArH2JBme
11/03/2022	10:17:40	4	1,982.00	XLON	xsqArH2JB7Q
11/03/2022	10:17:40	98	1,982.00	XLON	xsqArH2JB7S
11/03/2022	10:17:40	167	1,982.50	XLON	xsqArH2JB7U
11/03/2022	10:17:40	98	1,982.50	BATE	xsqArH2JB6Y
11/03/2022	10:17:40	35	1,983.00	BATE	xsqArH2JB6a
11/03/2022	10:17:40	20	1,983.00	BATE	xsqArH2JB6c
11/03/2022	10:17:40	387	1,983.00	XLON	xsqArH2JB6W
11/03/2022	10:17:40	88	1,983.00	BATE	xsqArH2JB6e

-- ENDS --

Enquiries:

Hikma Pharmaceuticals PLC
Peter Speirs Company Secretary	[phone]
Susan Ringdal EVP Strategy and Global Affairs	[phone]

About Hikma

Hikma helps put better health within reach every day for millions of people around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,700 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com .

(LEI:549300BNS685UXH4JI75)

 

END

 

 

POSVFLFFLXLBBBK